valacyclovir

Generic: valacyclovir

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name valacyclovir
Generic Name valacyclovir
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

valacyclovir hydrochloride 1000 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-7270
Product ID 50090-7270_50117a81-fa76-4abc-bb77-1d30f2274a20
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209553
Listing Expiration 2026-12-31
Marketing Start 2023-02-14

Pharmacologic Class

Classes
dna polymerase inhibitors [moa] herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc] nucleoside analog [ext]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500907270
Hyphenated Format 50090-7270

Supplemental Identifiers

RxCUI
313564
UNII
G447S0T1VC

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name valacyclovir (source: ndc)
Generic Name valacyclovir (source: ndc)
Application Number ANDA209553 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1000 mg/1
source: ndc
Packaging
  • 15 TABLET in 1 BOTTLE (50090-7270-0)
  • 21 TABLET in 1 BOTTLE (50090-7270-1)
  • 30 TABLET in 1 BOTTLE (50090-7270-2)
  • 90 TABLET in 1 BOTTLE (50090-7270-3)
source: ndc

Packages (4)

50090-7270-0 15 TABLET in 1 BOTTLE (50090-7270-0) 50090-7270-1 21 TABLET in 1 BOTTLE (50090-7270-1) 50090-7270-2 30 TABLET in 1 BOTTLE (50090-7270-2) 50090-7270-3 90 TABLET in 1 BOTTLE (50090-7270-3)

Ingredients (1)

valacyclovir hydrochloride (1000 mg/1)

Linked Drug Pages (1)

Valacyclovir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "50117a81-fa76-4abc-bb77-1d30f2274a20", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["6719e877-cff4-4be8-a352-8df0afa4f74c"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (50090-7270-0)", "package_ndc": "50090-7270-0", "marketing_start_date": "20241008"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (50090-7270-1)", "package_ndc": "50090-7270-1", "marketing_start_date": "20241008"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-7270-2)", "package_ndc": "50090-7270-2", "marketing_start_date": "20241008"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-7270-3)", "package_ndc": "50090-7270-3", "marketing_start_date": "20241008"}], "brand_name": "Valacyclovir", "product_id": "50090-7270_50117a81-fa76-4abc-bb77-1d30f2274a20", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50090-7270", "generic_name": "Valacyclovir", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20261231"}